1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993. 329:977–986.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998. 352:837–853.
3. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002. 87:978–982.
4. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000. 355:773–778.
5. Ceriello A. Acute hyperglycemia: a 'new' risk factor during myocardial infarction. Eur Heart J. 2005. 26:328–331.
6. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemia damage. Nature. 2000. 404:787–790.
7. Gutterman DD. Vascular dysfunction in hyperglycemia: is protein kinase C the culprit? Circ Res. 2002. 90:5–7.
8. Gresele P, Guglielmini G, De Angelis M, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol. 2003. 41:1013–1020.
9. Marfella R, Esposito K, Giunta R, et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation. 2000. 101:2247–2251.
10. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002. 106:2067–2072.
11. Akbari CM, Saouaf R, Barnhill DF, Newman PA, LoGerfo FW, Veves A. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg. 1998. 28:687–694.
12. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 1999. 34:146–154.
13. Title LM, Cummings PM, Giddens K, Nassar BA. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol. 2000. 36:2185–2191.
14. Beckman JA, Goldfine AB, Gordon MB, Creager MA. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation. 2001. 103:1618–1623.
15. Youn HJ, Foster E. Demonstration of coronary artery flow using transthoracic Doppler echocardiography. J Am Soc Echocardiogr. 2004. 17:178–185.
16. Park JH, Kang DH, Lee SW, et al. Detection of coronary restenosis by serial Doppler echocardiographic assessment of coronary flow velocity reserve after percutaneous intervention. Korean Circ J. 2004. 34:660–669.
17. Choi CU, Shim WJ, Kim SH, et al. Factors affecting coronary flow reserve: measured by transthoracic Doppler echocardiography. Korean Circ J. 2002. 32:958–964.
18. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1918. 7:353–370.
19. Capaldo B, Galderisi M, Turco AA, et al. Acute hyperglycemia does not affect the reactivity of coronary microcirculation in humans. J Clin Endocrinol Metab. 2005. 90:3871–3876.
20. Fusimoto K, Hozumi T, Watanabe H, et al. Acute hyperglycemia induced by oral glucose loading suppresses coronary micocirculation on transthoracic doppler echocardiography in healthy young adults. Echocardiography. 2006. 23:829–834.
21. Weiss D. Hyperglycemia during physical stress. Am J Med. 1996. 100:374.
22. Galderisi M, de Simone G, Cicala S, et al. Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass. J Hypertens. 2003. 21:2183–2188.
23. Youn HJ, Park CS, Cho EJ, et al. Analysis of coronary artery flow patterns in patients with chest pain and normal coronary angiogram: study using transthoracic Doppler echocardiography. Korean Circ J. 2003. 33:205–211.
24. Nemes A, Forster T, Csanady M. Decreased aortic distensibility and coronary flow velocity reserve in patients with significant aortic valve stenosis with normal epicardial coronary arteries. J Heart Valve Dis. 2004. 13:567–573.
25. Kim HK, Kim YJ, Sohn DW, Park YB, Choi YS. Transthoracic echocardiographic evaluation of coronary flow reserve in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2004. 94:167–171.
26. Ceriello A, Quagliaro L, D'Amico M, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes. 2002. 51:1076–1082.
27. Gupta S, Sussman I, McArtliur CS, Tornheim K, Cohen RA, Ruderman NB. Endothelium-dependent inhibition of Na+-K+ ATP ase activity in rabbit aorta by hyperglycemia: possible role of endothelium-derived nitric oxide. J Clin Invest. 1992. 90:727–732.
28. Joffe II, Travers KE, Perreault-Micale CL, et al. Abnormal cardiac function in the streptozocin-induced non-insulin-dependent diabetic rat: non-invasive assessment with Doppler echocardiography and contribution of nitric oxide pathway. J Am Coll Cardiol. 1999. 34:2111–2119.
29. McVeigh G, Brennan G, Hayes R, Cohn J, Finkelstein S, Johnston D. Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am J Med. 1993. 95:424–430.
30. Eckel RH, Wassef M, Chait A, et al. Diabetes and cardiovascular disease: writing group II: pathogenesis of atherosclerosis in diabetes. Circulation. 2002. 105:e138–e143.